Skip to main content

TG Therapeutics, Inc.

TGTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001001316

In the last 90 days, TG Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 430 institutions reported holding it in 13F filings for Q2 2026, worth $6.10B in total; no superinvestor holds it.

Members of Congress who traded TGTX

Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.

Trades
1
Filings
1
Members
1
Buys / sells
0 / 1
Estimated volume
$8.00K
Sum of range midpoints
Members of Congress who traded TGTX
MemberTradesBuys / sellsEst. volumeLast tradedLast filed
Chris JacobsRepublican · House · NY10 / 1$8.00KSep 8, 2020Nov 6, 2020

Trades

Every reported trade in TG Therapeutics, Inc., newest filings first.

Congress trades
MemberAssetTypeOwnerTradedFiledDelayAmountSource
Chris JacobsRepublican · House · NYTGTXTG Therapeutics, Inc.Sell (partial)SelfSep 8, 2020Nov 6, 202059 daysLate$1K-$15KFiling

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.